Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving
October 16 2024 - 9:00AM
Business Wire
Know Labs Retains the Stanbridge Group to
Secure Automotive Joint Venture Partnerships
Know Labs, Inc. (NYSE American: KNW), a leading developer of
non-invasive sensor technology, announced today that it has
retained The Stanbridge Group to secure a strategic relationship
with an automotive original equipment manufacturer to embed the
Know Labs sensor technology in automobile steering wheels. In early
preliminary tests, the Know Labs sensor demonstrated, in a
laboratory setting, that it can non-invasively determine blood
alcohol levels and the Company believes, in an automobile steering
wheel, could prohibit an impaired individual from driving.
This discovery occurred during the early development of the
Company’s non-invasive glucose monitoring technology. That lead to
the filing in 2022 by Know Labs of a patent entitled, “Vehicle
Interface Systems and Methods for Analyte-Based Control” on August
15, 2022. It was published on February 15, 2024, with publication
number: US 2024/0050007 A1.
Tucked within President Biden's 2021 Infrastructure Investment
and Jobs Act is a mandate set to redefine the landscape of DUI
prevention. By as early as 2026, all new vehicles sold within the
country will need to be equipped with passive alcohol detection
systems. The Know Labs platform directly addresses this issue.
“While inventing and developing the Know Labs non-invasive
diagnostic technology we have paid close attention to the many
diverse fields of use in which our technology could be applied,”
said Ron Erickson, Know Labs’ CEO. “Determining driver health and
wellness is one of those fields of use. Our broad patent portfolio
covers installing our sensor technology in an automobile steering
wheel. We believe our sensor technology, embedded in steering
wheels, can keep drunk drivers off the road and become the standard
for the global auto industry. The Stanbridge Group is working to
secure a joint venture partner for this exciting application of our
platform technology while we continue the Company’s core focus on
non-invasive blood glucose monitoring.”
In 2022, drunk driving was responsible for 13,524 deaths in the
United States according to the National Highway Traffic Safety
Administration (“NHTSA”). As a consequence, NHTSA has initiated a
proposed rule making process regarding Advanced Impaired Driving
Prevention Technology.
The Stanbridge Group, led by founder, Rick Stanbridge, has
worked with senior leadership of automobile and original equipment
automobile equipment manufacturers for many years. “Automobile and
component manufacturers are all looking for a way to prevent
impaired drivers from operating their vehicles,” stated Rick
Stanbridge. “The Know Labs sensor is a perfect solution for the
problem manufacturers and the NHTSA are working to solve. We are
thrilled to be working with Know Labs on this important
project.”
For more information on Know Labs, visit www.knowlabs.co.
About Know Labs, Inc.
Know Labs, Inc. is a public company whose shares trade on the
NYSE American Exchange under the stock symbol “KNW.” The Company’s
platform technology uses spectroscopy to direct electromagnetic
energy through a substance or material to capture a unique
molecular signature. The technology is designed to able to
integrate into a variety of wearable, mobile or bench-top form
factors. The Company believes that this patented and patent-pending
technology makes it possible to effectively identify and monitor
analytes that could only previously be performed by invasive and/or
expensive and time-consuming lab-based tests. The Company’s first
expected application of the technology will be in a product
marketed as a non-invasive glucose monitor. The device is designed
to provide the user with accessible and affordable real-time
information on blood glucose levels. This product will require U.S.
Food and Drug Administration clearance prior to its introduction to
the market.
About The Stanbridge Group
The Stanbridge Group conducts business in the United States and
around the world. Their focus is on helping companies grow to the
next level of expansion and profitability regardless of their
geographic location. Most people forget that behind every large
corporation there was once a small business. All the big corporate
names here in the United States began as an entrepreneurial idea,
with only a few employees, a market to fill, and the will and
vision to grow. The Stanbridge Group has the tools and resources to
take your business to the next level. For more information on The
Stanbridge Group, visit www.thestanbridgegroup.com
Safe Harbor Statement
This release contains statements that constitute forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 and Section 27A of the Securities Act of 1933,
as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended. These statements appear in a number of places in this
release and include all statements that are not statements of
historical fact regarding the intent, belief or current
expectations of Know Labs, Inc., its directors or its officers with
respect to, among other things: (i) financing plans; (ii) trends
affecting its financial condition or results of operations; (iii)
growth strategy and operating strategy; and (iv) performance of
products. You can identify these statements by the use of the words
“may,” “will,” “could,” “should,” “would,” “plans,” “expects,”
“anticipates,” “continue,” “estimate,” “project,” “intend,”
“likely,” “forecast,” “probable,” “potential,” and similar
expressions and variations thereof are intended to identify
forward-looking statements. Investors are cautioned that any such
forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, many of which are beyond Know
Labs, Inc.’s ability to control, and actual results may differ
materially from those projected in the forward-looking statements
as a result of various factors. These risks and uncertainties also
include such additional risk factors as are discussed in the
Company’s filings with the U.S. Securities and Exchange Commission,
including its Annual Report on Form 10-K for the fiscal year ended
September 30, 2023, Forms 10-Q and 8-K, and in other filings we
make with the Securities and Exchange Commission from time to time.
These documents are available on the SEC Filings section of the
Investor Relations section of our website at www.knowlabs.co. The
Company cautions readers not to place undue reliance upon any such
forward-looking statements, which speak only as of the date made.
The Company undertakes no obligation to update any forward-looking
statement to reflect events or circumstances after the date on
which such statement is made.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241016059079/en/
Know Labs, Inc. Contact: Jordyn Hujar jordyn@knowlabs.co
Ph. (206) 629-6414
Know Labs (AMEX:KNW)
Historical Stock Chart
From Oct 2024 to Nov 2024
Know Labs (AMEX:KNW)
Historical Stock Chart
From Nov 2023 to Nov 2024